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Somatostatin receptor (SSTR) subtype genes are differentially expressed in brain and various peripheral tissues. RNA blotting and semiquantitative 
PCR analyses have revealed low levels of SSTRl mRNA in the gastrointestinal tract and relatively high levels in GH, anterior pituitary cells. As 
a first step in the investigation of the regulation of SSTRl gene expression, we isolated a genomic fragment hat contains the promoter region and 
determined the transcriptional initiation site. The SSTRl gene lacks introns and TATA and CAAT motifs, but possesses several consensus recognition 
sequences for the transcription factors GCF and AP-2. The presence, also, of two Pit-l binding sites could explain the high SSTRl mRNA levels 
in GH, cells. 
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1. lutroduction 
The diverse biological activities of the peptide 
hormone somatosmtin are mediated by at least five dif- 
ferent receptors, termed SSTRI-5 [l-7], that belong to 
the superfamily of:G-protein coupled receptors each of 
which contains seven transmembrane domains. When 
expressed individually in mammalian cells the five recep- 
tor subtypes exhibit distinct pharmacological properties, 
yet, when activated, all inhibit adenylate cyclase [8]. 
RNA blot analysis and nuclease protection and in situ 
hybridization experiments how a spatially and tempo- 
rally different localization of the individual SSTR 
mRNAs in brain and peripheral tissues [9]. For instance, 
in rat brain areas such as the cortex and the magnocellu- 
lar preoptic nucleus SSTRI transcripts are first observed 
at prenatal day 14 and increase in number until prenatal 
day 20 [5]. However, SSTRI mRNA levels then decrease 
in the magnocellular preoptic nucleus during further de- 
velopment being barely detectable by in situ hybridiza- 
tion in adult animals; in contrast, they remain unchanged 
in cortex. The heterogeneous mRNA distributions point 
to different physiological roles for the various receptor 
subtypes and reflect the complex regulation of expres- 
sion of the five genes. 
By RNA blot analysis and polymerase chain reaction 
(PCR) amplification we have further examined the distri- 
bution of SSTR mRNAs in peripheral organs. To gain 
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a frrst insight into the mechanism of gene regulation, we 
have also isolated and characterized the rat SSTRI gene. 
2. Materials and methods 
2.1. Isolation of genomic lones 
A rat genomic library constructed in lambda DASH II (Stratagene) 
was screened by standard protocols [lo] with a 1,276 bp fragment hat 
contained the entire coding region of the rat SSTRl cDNA [3]; this was 
obtained by PCR amplikation using the primers 5’-TGAGCTGT- 
GAGCTTGGAG-3’ and 5’-TCAAAGCGTGCTGATCCT-3’. Posi- 
tive plaques were purified and one clone, kg1 . 1, was chosen for further 
analysis. 
2.2. Mapping, subcloning and sequencing 
The 19 kb insert of Lrgl . 1 was analyzed by restriction mapping and 
Southern blot hybridizations. Appropriate restriction fragments were 
subcloned into pBluescript II SK+ (Stratagene) and sequenced either 
manually [l l] or with the help of an Applied Biosystems model 373A 
DNA Sequencer. 
2.3. Primer extension 
Primer extension was performed essentially as described [lo] using 
poly(A)+ RNA from GH, cells and a “‘P end-labeled antisense 30-base 
oligonucleotide 5’-GACGCTCACCTTGCGCCCTTGCTGCCTGC- 
G-3’ corresponding to nucleotides 94123 of the cloned rat SSTRl 
cDNA [3]. 20 pg RNA was mixed with 5 x 10’ cpm of primer (specific 
activity lo7 cpmlpmol) in 30 ~1 hybridization buffer which contained 
80% (v/v) formamide, 40 mM PIPES @H 6.4), 1 mM EDTA (pH 8.0) 
and 0.4 M NaCl. Following incubation at 8O’C for 5 min the mixture 
was hybridixed overnight at 32°C. After extension for 1 h at 37°C with 
200 units M-MLV reverse transcriptase (Stratagene), products were 
analyzed in 6% denaturing polyacrylamide gels. 
2.4. RNA blot analysis and semiquantitative PCR analysis 
Preparation of total RNA, isolation of poly(A)+ RNA, RNA blot 
and semiquantitative PCR analysis were carried out as described previ- 
ously [12]. As hybridization probe for RNA blot analysis, the complete 
SSTRl cDNA [3] was radiolabeled by the random priming method [IO]. 
3. Results and discussion 
Previous studies have shown that SSTRI [3] and 
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Fig. 1. (A) Northern blot analysis of rat SSTRl mRNA in peripheral tissues. Poly(A)+ RNA (1Opg) isolated from GH, cells (l), stomach (2), pancreas 
(3), duodenum (4) and jejumnn (5) was eleotrophoresed, blotted and hybridized with a radiolabelled SSTRl cDNA probe. (B) Relative abundance 
of SSTRl-4 mRNAs analyzed by semiquantitative PCR. AmpliCed cDNAs generated using specific primers were dot-blotted, hybridized with 
subtype-specik oligonucleotide probes and quantilkd using a PhosphoImager as described previously [12]. 
SSTR3 [5] mRNAs are present in various rat brain re- 
gions [5,12]. To investigate the possible physiological 
roles of the different SSTRs, the distributions of SSTR 
mRNAs in peripheral tissues were analyzed. RNA blot 
analysis revealed high levels of the 3.8 kb SSTRl tran- 
script in rat anterior pituitary GH, cells and lower levels 
in stomach, duodenum and jejunum (Fig. 1A). No 
SSTRl transcripts were detected in the pancreas, and no 
SSTR3 mRNA has been observed in any of the above 
tissues when using this technique (data not shown). To 
analyze the SSTR mRNA distributions in greater detail 
and at higher sensitivity, semiquantitative PCRs have 
been employed. Fig. 1B reveals that the different tissues 
contain distinct sets of SSTR mRNAs. Thus, SSTRl 
probably has an important role in anterior pituitary GH, 
cell function. SSTR2 also seems to be involved in pitui- 
tary function, while SSTR4 may be important for gastro- 
intestinal and pancreatic physiology. 
These results, which are in line with previous reports 
[9] strongly suggest hat SSTR gene expression is subject 
to finely tuned regulatory mechanisms. In order to begin 
to examine the molecular details of this regulation, the 
SSTRl gene was isolated. Sequence analysis of a 7.4 kb 
EcoRI-Hind111 fragment revealed that it contains the 
entire previously reported cDNA sequence [3], which 
lacks introns, about 2 kb of S-flanking DNA and 1.7 kb 
of 3’-flanking DNA (Fig. 2). 
The transcriptional start site of the SSTRl gene was 
determined using poly(A)+ RNA from GH3 cells that 
contain a relatively large amount of the corresponding 
mRNA. Fig. 3 shows a major primer-extended product, 
corresponding to a guanosine residue, 178 bp upstream 
from the translation initiation site. In addition, three 
minor extension products are observed corresponding to 
positions -2, -1 and + 2 of the SSTRl gene (Fig. 2). 
The nucleotide sequence upstream of the SSTRl 
mRNA start site contains neither a canonical TATA box 
nor a CAAT box but possess sequences having a high 
GC content. These features are reminiscent of promoters 
of ubiquitously-expressed housekeeping genes [ 13,141 
such as the human dehydrofolate reductase, hypoxan- 
thine phosphoribosyl transferase and phosphoglycerate 
kinase genes [ 15-171. However, promoters lacking a 
TATA box but containing GC rich sequences can also 
be found in genes involved in growth control such as the 
gene for the human epidermal growth factor receptor 
[ 181 and the cellular proto-oncogene Ha-ras [ 191. In addi- 
tion, it is worth noting that the promoter for another 
G-protein coupled receptor, namely the rat serotonin 
5-HT2 receptor, also lacks a TATA motif [20]. 
Table 1 
Putative regulatory elements in the Y-flanking region of the rat SSTRl 
gene 
Pit-l 5' 3' 
consensus A/T T A T C/T C A T 
-1952 T T A T T C A T -1959 
-110 A T A T C C A T -117 
GCF 5' 3' 
consensus G/C C G G/C G/C G/C C 
-1084 G C G G C G C -1078 
-1054 G C G C G G C -1060 
-1010 C C G C G C C -1004 
-954 G C G G G G C -960 
-656 G C G C C G C -650 
-233 C C G C C C C -239 
-200 G C G C C C C -194 
-192 C C G C C G C -186 
AP-2 5' 3' 
consensus C C C A/C N G/C G/C G/C 
-1374 C C C A T C C C -1381 
-1343 C C C C A G G C -1350 
-1127 C C C C A C C C -1120 
-906 C C C C C C C C -913 
-197 C C C C C C C G -190 
-99CCC A G C G C -106 
Consensus sequences recognized by the transcription factors are from 
[26]. The numbering of the putative regulatory elements corresponds 
to that of Fig. 1. 
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GAATTCCACTCTMCATTTTTTTCT- TTCAGCATCTGTTACACACACTCTTAGGGAGTCTGTGGTCATTGATTTTMTCTGACTGCCTCTGCCATCATGGACACCGCACGTG 
ATTCTTTCTCTCCTAGCAGCACTGAGTTTGGGAGAGCGAGCGAGGMTCCATGTGTAGGCMTTTCTGAGMCMGCMCMGCCATTGTTGGATTGATGCTTTACTTTTMTGCGGTGTCCM 
CTCTGTGCACTCTAGACTGTCTGGTAGGGACAGCTTCGGTAAATTTGGGTTT~TTTACCTCCTCTTGGTGGAGATGTTAGAGGGAGACTAGGMGACAGCAATTGTGAGCAGCAGCCCAGC 
TCCAGGTGAGCACTGGACTGCAGCGGCMGTCTTCCTGAGACTTGGCATGCTTCCTGCAAAGACTTGCAGGGATTTCCGTG~AGGMATTCCTTTCATG-GGAATAGGTGGTTGM 
TCATTTAGCAGAGAGTAGCTGTAAGGCCAAAGAGAGACCCTAGGTTCAGAGTCCTGGGAACTCCCAAGGTCCCTT~MTCAACITCCATCCATTCTTTCTCMTCMGAGCCTGTAGTTCCCAG 
ACTTGGGATGGGMCTGCAGGTCGATGAGCTTTGAGCCTGGGGCTTTMTMCTATATCTTMTGGTTTTAGCATTTGGMCACAGAGGGGGTTATCCCTCMGGCTCTACTATCCCTTA 
GTATTCCATAGGGGMAGCTTGAAAGTCTTGCCACTGTTCCCAGGCTTGATGACAGTCCATCAGTTGCTCAGCCAGCCACGCGTGGATTMGACTGTCGCGCCTGCCTATTCTGGCCTTG 
GCGCTCTCCACCTCCATC $&&&&CGCCAACTCTCCCGGGTACMAGTACAGCCGGGAC~ GGGAGCAGCTGTTCC DAGCCTAATCTTTCCCCAGTGAACACCTA 
CATGGATTTCCMTACCGCGCCTGGCAGGTTCCGGAGGGAGTGCCAGCCTCCTCCTGAGCTCTCT aATTCTGACTTCTGCAGTGGATATCCCTAGGGGAGGTGGGG_ 
GGCAGGGCTCAGGGMTTACAGCTTTGTTAGACAGTCGCMTGGTTCCACTGAGTCCCCCTGMCACTCCCTGCTGCAGAGTGGAGGGCGATGGATGTTGTAACTCAGCATCCCTTMC 
ACACCACTGTAGTCCTCCGTGCTCATMTGCTATTGGCTTAGGTCTGGTTTCCACCGCTCAGTGTTTGCGTGGGCACTTGTGCAGCAGCCAGCCCCAMGGGAGTTGGACG 
MCGTCAGA~CGCCGCCAGACCTCACMGCACTTTGCAAGGGCCATCTGGAGACATCGATTTTAGG~CCCGACGACCTGAMTCTCCAGGTACAGTTTTGMGACTGGCMGCAGG~ 
GGAGGTAGGTGTTTAGGGTCCGGTCCTGMGAGTGTCTTAGGGACAGGTGMGTCGCCCCCATCACCAGMGAGAGCAGCAGCAG~G~TGMGAGGMCTCCAGACATGTATGTCT 
GGGGTTTGCTTCGGTCTTTACTTAGAGTAGGAGTGGTGTGGAACGGGACAGAATCTACATTCGTGACTGGCACCTACCCTTTAGMAGGMGAAACTCCTCAGGTCTGTCCTCGGMT 
GACTGMGATGCTATGAGAGAMTCTGAAGCMTCTTTGAGTTGAGCTTAGAGGGGACTAGMTTGGGGGCGGGAGCGATGACGGGAGMTMACCACCTATGTG~CCCGCGC 
TTTTTCGTAGCTGCTGACGCGATGGTGCTGCTTATTMTCATTCATCAGTCCAGAGCCTTTCCACTT l lm TCGCGCTGGGCTCTAGCCTCTTGACCTCTCCTCTCCTCTTCTT - 
TCCACGCTCCAGTGTATCCAGGACCCCCAGAGCTGC~GAGACAGCGCTCMGCAAGCAGCCGC~GCGTTGCGCCAGACGGCCTCAGTTGGAGCCGC..3615 bp cD"A..TGTTG 
CAAGTTGTCTGGCTTCCATTTGAATCTTCGCTGTTTCAAGGGGTTATTTGMTGCATGGGTATGATTGACATGCTTAGTTTTTAGGMMTTTCMGTTMCTTTGAMTTTCACMGAT 
TGCCTCATCCTTTGMTTGTTTTCTTTTAAATGTGGATCCTGGTGTGCATGTCCTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTACTAGACMGGAGGG 
MGAAGGAGGGTMAGAGGAGGGTAAGGAGGAGGAGGAATAATGTCCCTTGMTGAGTTTGMCAGGMGCAATGCCCTAGGTTACACTCTGTTCTCACTACAC 
TMCCAGACMTGTCTCTGTTTTTCACAGATTAMATTACTGGCTGACCTCATTTATGACCTCAGATTTTGCCCTCGAGTTTAGTGACCGCTGCTTTGCATTAGAGACATAGCMTGGGA 
GGGAGAAACATCTCTTAAAGTGTTGGMGGGMGTGGAGA~G~TAG~CCAGGTTTTGAGGAGGACACATTTTATGCCTTCCTCAGTTTTGACCATTTCCATGATG~GGCCA 
TAACMGGCTTGGTGGAGATCATTTTTTTMGCAGGTTCTGTGATTTATAGCAGCTTTATTTTCACAGC-T~TGAAAGGCATTCCTCAAGCATTTGAGAGCAGTMGTCTACT 
GTGATAGTGGTTGAMGTGTCMMGCCCTGCAACCCCAGCTTCATGTAGTTATAGACATCAGCTCACMTGACTMGGCMGGGATGCTTTTACATTTTCACCATTTCTC~GTCGTA 
GCMGGTAGCAAATGCAAAGTTAAGTTTACAACTTAGATTTGTMCATCCTTTTCTTAGTGCTGCMTTGGGCCCAGTTCCTCTACACATAATTTGTTMTTTAGTCTTAACTACTCTM 
ACATTCCGAAAACCCTTCAAACTAGTTTTCAMCTGGGAGCMAGAGACAGTTGAGCTAATAATTTAAATAGCTATTTTTAMGTTGCTTTTATTTAGGTTTGTACAGTATCACAGCTAG 
CACCTCTCTCTTATMCTAARRTGGCACTAAATGGTGCTTATATGGTGTAGGATGCACTACATACCCTAGTGGGTAAATATGACTGGGTTGAGCCCTTGGGG~GTGGCCCTCCAGGTC 
CTTCCCCTTTTGTGMATGTTTTCCCAGCTGCAGTTGGGCAACATTTGCMTTCTAGAACTGGGGAGCCTCCATCCATCTGACAGATCCAGGTCGGGTTGTAGCCCTGGAGTCCGGTGGCT 
CTCACACTGATCACCAGTCCAGTGGATMCACAGACTGCACAGAGTCTGACGCCTGCCATGGCAGCTCCTGGCTCAGTGGCTAGAGGGGGACCTAGGATAGCTGGTACTAGATGTGCTCCA 
GCATCACCGTGGTCTGCTCTTGTCTCCCTCTGCCAAAGGCTGTCTCAAATCTTCTGTATTTATCTTTGTTTCTGTCMCCTCACTTACTGAACATTTCCTATTCTCTATMCTGCTTTGT 
ACTAGAGGAMACCATGAGTTAAATCCTGTTCCTTAGCCCTGGGTCCCATGCAGAAGGAAAGTGTTAAGCTMTTCCTACTCCTTCCCCMCCAGGCTTACACCTGATTCCCMGMATT 
TTCATTTCCTAACTATAAACCCTTCTCCTATCCTCAGGTGATMGCTT 
Fig. 2. (A) Restriction map of the cloned genomic DNA fragment containing the rat SSTRl gene. The open box represents the relative position of 
the previously reported cDNA sequence [3] and the black box indicates the coding region. The fragment from the EcoRI to the first Hind111 restriction 
site downstream of the coding region was sequenced. (B) Nucleotide sequence of the rat SSTRl gene and flanking regions. The sequence is numbered 
from the major transcriptional initiation site (+l) which is indicated by an arrow. The putative regulatory elements in the 5’-flanking region are 
underlined (GCF), doubly underlined (AP-2) and boxed (Pit-l), respectively. 
Analysis of the SSTRl gene sequence reveals the pres- recognition sequences for another transcription factor 
ence of many potential regulatory DNA elements in the 
5’-flanking region (Table 1). There are eight putative 
interacting with GC boxes, AP-2 [22], are observed. Two 
binding sites for the GC-factor (GCF), three of them in 
of these are located within the first 200 bp upstream of 
the mRNA initiation site. Interestingly, two elements 
close proximity to the transcriptional initiation site. 
GCF is a transcriptional repressor that binds to GC-rich 
that have the consensus equence of the binding site for 
the transcription factor Pit-l (also called growth 
sequences or GC boxes that are often found in promoters hormone factor 1) [23,24], are found at positions -107 
lacking a TATA motif [21]. In addition, six putative and -1,951. Pit-l is a POU-domain protein, which is 
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Fig. 3. Primer-extension analysis of the 5’-terminus of the rat SSTRl 
mRNA. Poly(A)+ RNA from the GH, cell-line (1) and an equal amount 
of yeast tRNA (2) were hybridized with a 3zP-labelled oligonucleotide 
complementary to part of the rat SSTRl cDNA sequence and then 
subjected to reverse transcription. The same oligonucleotide was used 
in a sequencing reaction with the genomic clone. Synthesized DNA 
products of the C reaction (C; exposure time 16 h) were run as a marker 
in parallel with the primer-extended products (exposure time 48 h). 
restricted to the adult anterior pituitary and has been 
implicated in the regulation of the tissue specific expres- 
sion of both the prolactin and growth hormone genes 
[25]. The presence of Pit-l recognition sequences in the 
rat SSTRl gene might explain the relatively high levels 
of SSTRl mRNA in the pituitary [9] and the pituitary- 
derived, prolactin- and growth hormone-secreting GH, 
cell-line (Fig. 1). This hypothesis is attractive because it 
suggests that peptide hormone genes and the gene for a 
receptor involved in the control of peptide hormone se- 
cretion are subject o common transcriptional regulatory 
mechanisms. However, evidence in support of a func- 
tional role for the identified sites must await further 
experiments. 
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